Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-22 Purchase |
2023-12-26 4:29 pm |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina GKCC LLC Director 10% Owner |
1,213,000 | $5.81 | $7,047,530 | 1,915,639 (Indirect) |
View |
2021-02-09 Sale(A) |
2022-05-27 4:20 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
159,177 | $16 | $2,546,832 | 1,439,525 (Direct) |
View |
2021-02-09 Sale(A) |
2022-05-27 4:19 pm |
Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director |
246,720 | $16 | $3,947,520 | 823,117 (Direct) |
View |
2022-05-25 Purchase |
2022-05-27 4:18 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
11,313 | $1.2466 | $14,103 | 1,891,947 (Direct) |
View |
2022-05-20 Purchase |
2022-05-25 5:58 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
82,200 | $1.2339 | $101,428 | 1,721,457 (Direct) |
View |
2022-05-19 Purchase |
2022-05-23 7:48 pm |
Angion Biomedica Corp. | ANGN | Nissenson Allen Director |
9,383 | $1.1643 | $10,925 | 9,383 (Direct) |
View |
2021-12-27 Purchase |
2021-12-29 4:08 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
277,244 | $2.6344 | $730,373 | 1,639,257 (Direct) |
View |
2021-12-20 Purchase |
2021-12-22 4:06 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
3,527 | $2.5449 | $8,976 | 1,362,013 (Direct) |
View |
2021-12-20 Sale |
2021-12-21 4:25 pm |
Angion Biomedica Corp. | ANGN | Neylan John F. See Remarks |
358 | $2.6201 | $938 | 35,136 (Direct) |
View |
2021-12-16 Purchase |
2021-12-20 6:44 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
41,625 | $2.5454 | $105,951 | 1,358,486 (Direct) |
View |
2021-12-15 Purchase |
2021-12-17 5:13 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
77,604 | $2.4091 | $186,956 | 1,316,861 (Direct) |
View |
2021-12-15 Purchase |
2021-12-16 4:58 pm |
Angion Biomedica Corp. | ANGN | CURHAN GREGORY S See Remarks |
4,000 | $2.37 | $9,480 | 4,000 (Direct) |
View |
2021-12-14 Sale |
2021-12-15 4:06 pm |
Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks |
451 | $2.4171 | $1,090 | 30,399 (Direct) |
View |
2021-12-06 Sale |
2021-12-07 4:06 pm |
Angion Biomedica Corp. | ANGN | Goldberg Itzhak See Remarks |
32,118 | $3.3539 | $107,721 | 1,720,068 (Direct) |
View |
2021-12-01 Sale |
2021-12-03 6:03 pm |
Angion Biomedica Corp. | ANGN | Goldberg Itzhak See Remarks |
117,882 | $3.4798 | $410,211 | 1,752,186 (Direct) |
View |
2021-11-18 Sale |
2021-11-22 7:09 pm |
Angion Biomedica Corp. | ANGN | Neylan John F. See Remarks |
374 | $4.13 | $1,545 | 35,494 (Direct) |
View |
2021-11-15 Sale |
2021-11-17 6:02 pm |
Angion Biomedica Corp. | ANGN | Goldberg Itzhak See Remarks |
150,000 | $4.1937 | $629,051 | 1,870,068 (Direct) |
View |
2021-11-15 Sale |
2021-11-16 4:09 pm |
Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks |
433 | $4.4 | $1,905 | 30,850 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | Ashe Carol Gail Director |
4,100 | $0 | 4,100 (Direct) |
View |
2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director |
4,100 | $0 | 4,100 (Direct) |
View |
Ownership |
2023-06-12 5:14 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina Director |
0 | $0 | 707,164 (Indirect) |
View |
Ownership |
2023-06-12 5:12 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks |
0 | $0 | 135,492 (Direct) |
View |
Ownership |
2023-06-07 9:53 pm |
N/A 2027-12-27 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
0 | $0 | 90,299 (Direct) |
View |
Ownership |
2023-06-07 9:53 pm |
N/A 2032-12-06 |
Elicio Therapeutics Inc. | ELTX | Segal Assaf Director |
0 | $0 | 4,525 (Direct) |
View |
Ownership |
2023-06-07 9:48 pm |
N/A 2030-02-20 |
Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director |
0 | $0 | 17,078 (Direct) |
View |
Ownership |
2023-06-07 9:45 pm |
N/A 2031-02-01 |
Elicio Therapeutics Inc. | ELTX | Matthies Annette Chief Business Officer |
0 | $0 | 82,205 (Direct) |
View |
Ownership |
2023-06-07 9:40 pm |
N/A 2032-03-31 |
Elicio Therapeutics Inc. | ELTX | ADAMS JULIAN Director |
0 | $0 | 51,316 (Direct) |
View |
Ownership |
2023-06-07 9:37 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director |
0 | $0 | 222,033 (Direct) |
View |
Ownership |
2023-06-07 9:36 pm |
N/A 2032-03-31 |
Elicio Therapeutics Inc. | ELTX | Ashe Carol Gail Director |
0 | $0 | 14,909 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 5:25 pm |
N/A 2033-06-01 |
Elicio Therapeutics Inc. | ELTX | Piekos Brian Chief Financial Officer |
75,484 | $0 | 75,484 (Direct) |
View |
2022-07-01 Tax Withholding |
2022-07-11 7:54 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Goldberg Itzhak Director |
32,082 | $1.12 | 1,687,986 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 5:27 pm |
N/A 2032-06-09 |
Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 5:26 pm |
N/A 2032-06-09 |
Angion Biomedica Corp. | ANGN | Nissenson Allen Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 5:26 pm |
N/A 2032-06-09 |
Angion Biomedica Corp. | ANGN | WILSON KAREN J Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 5:26 pm |
N/A 2032-06-09 |
Angion Biomedica Corp. | ANGN | OMENN GILBERT S Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-02-09 Conversion(A) |
2022-05-27 4:20 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
262 | $11.57 | 1,439,525 (Direct) |
View |
2021-02-09 Exercise(A) |
2022-05-27 4:20 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
396,329 | $6.43 | 1,439,525 (Direct) |
View |
2021-02-09 Exercise(A) |
2022-05-27 4:20 pm |
N/A 2028-07-05 |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
396,329 | $0 | 1,439,525 (Direct) |
View |
2021-02-09 Exercise(A) |
2022-05-27 4:19 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director |
614,310 | $6.43 | 823,117 (Direct) |
View |
2021-02-09 Exercise(A) |
2022-05-27 4:19 pm |
N/A 2028-07-05 |
Angion Biomedica Corp. | ANGN | GANZI VICTOR F Director |
614,310 | $0 | 823,117 (Direct) |
View |
2022-03-03 Option Award |
2022-03-04 4:22 pm |
N/A 2032-03-02 |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
760,000 | $0 | 1,360,000 (Direct) |
View |
2022-03-02 Option Award |
2022-03-04 4:21 pm |
N/A 2032-03-01 |
Angion Biomedica Corp. | ANGN | Neylan John F. See Remarks |
275,000 | $0 | 450,000 (Direct) |
View |
2022-03-02 Option Award |
2022-03-04 4:21 pm |
N/A 2032-03-01 |
Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks |
275,000 | $0 | 450,000 (Direct) |
View |
2022-03-02 Option Award |
2022-03-04 4:20 pm |
N/A 2032-03-01 |
Angion Biomedica Corp. | ANGN | CURHAN GREGORY S See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
2021-06-24 Tax Withholding |
2021-12-17 5:13 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
41,091 | $13.78 | 1,316,861 (Direct) |
View |
2021-06-24 Tax Withholding |
2021-11-17 6:02 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Goldberg Itzhak See Remarks |
47,410 | $13.78 | 1,870,068 (Direct) |
View |